India on Friday stepped closer to getting its first Covid-19 vaccine with the expert committee of the national drug regulator recommending emergency use approval to the Oxford University/AstraZeneca/Serum Institute of India candidate Covishield.

Covishield gets expert panel nod, ball now in DCGI court

Morning Digest: Covishield vaccine gets approval from DCGI’s expert panel, farmers to escalate protest on January 4 if deadlock continues, and more

Expert panel recommends SII’s Covishield for emergency use: Sources

As expert panel recommends Covishield, health activists flag efficacy data